12 results

• Nesina Side Effects Not Linked To Cardiovascular Death Risk: Study

  June 16, 2016

  Irvin Jackson

  The findings of an new study indicate that the diabetes drug Nesina does not increase the risk of heart failure-related death in patients with acute coronary syndrome.

• Heart Failure Risk with Onglyza, Similar Diabetes Drugs Lead to FDA Warnings

  April 6, 2016

  Austin Kirk

  Onglyza and similar diabetes drugs may increase the risk of heart failure, according to an FDA warning that will lead to new label warnings being added to the drugs.

• Januvia Joint Pain Problems Result in FDA Warning for Class of Diabetes Drugs

  August 31, 2015

  Austin Kirk

  The FDA is warning that Januvia and similar diabetes drugs may be causing cases of severe joint pain among users.

• Onglyza Risks Lead Express Scripts to Drop Drug from 2016 Formulary

  August 5, 2015

  Irvin Jackson

  Onglyza and several other drugs have been dropped from Express Scripts insurance coverage lists due to health concerns and the presence of safer, affordable alternatives.

• Health Problems Linked to Invokana, Farxiga, Onglyza, Nesina in Adverse Event Reports

  June 29, 2015

  Irvin Jackson

  Some diabetes drugs unexpected linked to heart failure risks, new report finds.

• Nesina Heart Failure Side Effects Require Warning Update: FDA Panel

  April 17, 2015

  Irvin Jackson

  An FDA advisory panel has voted to add new label warnings to the diabetes drug Nesina.

• Onglyza Heart Failure Warnings Should Be Added, FDA Advisors Say

  April 16, 2015

  Irvin Jackson

  An FDA advisory committee is calling on the agency to add new warning labels to the diabetes drug Onglyza, including warnings of risks of heart failure and death.

• Onglyza Side Effects Increase Risk of Death, FDA Reviewers Warn

  April 13, 2015

  Austin Kirk

  FDA reviewers warn that the diabetes drug Onglyza may increase the risk of death in some patients.

• Nesina Leads Similar Diabetes Drugs in Adverse Events: Report

  April 17, 2014

  Irvin Jackson

  A look at diabetes drug adverse event reports suggests Nesina is the most dangerous and finds evidence of pancreatic cancer risks.

• No Heart Benefits Or Risks Found in Onglyza or Nesina Diabetes Drugs

  September 4, 2013

  Irvin Jackson

  A new study appears to show that some diabetes drugs neither increase the risk of heart problems or prevent them.